Current Concepts in Hematopathology 2022 ( VIDEOS)

Overview

Current Concepts in Hematopathology 2022 ( VIDEOS) is an on-demand digital education program featuring expert discussions on the microscopic evaluation of hematolymphoid disorders. This course covers the appropriate use of ancillary studies, including morphologic interpretation, immunophenotyping, cytogenetics, and molecular testing to support diagnosis. On-demand hematopathology education — accessible anytime, anywhere.

Agenda

This comprehensive video course includes detailed presentations and moderated question and answer sessions covering a wide spectrum of hematopathology topics:

• Nodal Small B-Cell Lymphomas — Elizabeth A. Morgan, MD
• Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma — Valentina Nardi, MD
• Question & Answer — Robert P. Hasserjian, MD (Moderator), Elizabeth A. Morgan, MD, Valentina Nardi, MD
• Immunodeficiency and Viral-Associated Lymphoproliferations — Judith A. Ferry, MD
• Updates in Cutaneous Lymphomas — Sam Sadigh, MD
• Question & Answer — Elizabeth A. Morgan, MD (Moderator), Judith A. Ferry, MD, Sam Sadigh, MD
• WHO Update – Follicular Lymphoma and Related Entities — Abner Louissaint Jr., MD, PhD
• Diffuse Large B-Cell Lymphoma Subtypes — Scott B. Lovitch, MD, PhD
• Question & Answer — Marian H. Harris, MD (Moderator), Abner Louissaint Jr., MD, PhD, Scott B. Lovitch, MD, PhD
• Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update — Aliyah R. Sohani, MD
• Reactive Lymphadenopathies and Castleman Disease — Yasodha Natkunam, MD, PhD
• Question & Answer — Robert P. Hasserjian, MD (Moderator), Yasodha Natkunam, MD, PhD, Aliyah R. Sohani, MD
• Approach to Peripheral Smear Review — Elizabeth Courville, MD
• Myelodysplastic Syndrome and Its Differential Diagnosis — Robert P. Hasserjian, MD
• Question & Answer — Elizabeth A. Morgan, MD (Moderator), Elizabeth Courville, MD, Robert P. Hasserjian, MD
• Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage — Olga K. Weinberg, MD
• Acute Lymphoblastic Leukemia — Marian H. Harris, MD, PhD
• Question & Answer — Robert P. Hasserjian, MD (Moderator), Marian H. Harris, MD, PhD, Olga K. Weinberg, MD
• Eosinophilia and Mastocytosis — Olga Pozdnyakova, MD, PhD
• Myelodysplastic/Myeloproliferative Neoplasms — Robert P. Hasserjian, MD
• Question & Answer — Marian H. Harris, MD, PhD (Moderator), Robert P. Hasserjian, MD, Olga Pozdnyakova, MD, PhD
• Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia — Sa A. Wang, MD
• Practical Interpretation of Molecular Testing in Myeloid Neoplasms — Annette S. Kim, MD, PhD
• Question & Answer — Elizabeth A. Morgan, MD (Moderator), Annette S. Kim, MD, PhD, Sa A. Wang, MD
• Challenges in the Diagnosis of Hodgkin Lymphomas — Marian H. Harris, MD, PhD
• Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas — Scott J. Rodig, MD, PhD
• Question & Answer — Robert P. Hasserjian, MD (Moderator), Marian H. Harris, MD, PhD, Scott J. Rodig, MD, PhD
• Indolent T-Cell Disorders — Kathleen H. Burns, MD, PhD
• Nodal T-Cell Lymphomas — Roberto Chiarle, MD
• Question & Answer — Marian H. Harris, MD, PhD (Moderator), Kathleen H. Burns, MD, PhD, Roberto Chiarle, MD
• Histiocytic and Dendritic Cell Neoplasms — Elizabeth A. Morgan, MD
• IgG4-Related Disease and Lymphadenopathy — Jacob R. Bledsoe, MD
• Blastic Plasmacytoid Dendritic Cell Neoplasm — Gabriel K. Griffin, MD
• Question & Answer — Marian H. Harris, MD, PhD (Moderator), Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD, Elizabeth A. Morgan, MD
• Inherited Predisposition to Myeloid (and Hematological) Malignancies — Mark D. Fleming, MD, DPhil
• Spleen Pathology — Lawrence R. Zukerberg, MD
• Question & Answer — Elizabeth A. Morgan, MD (Moderator), Mark D. Fleming, MD, DPhil, Lawrence R. Zukerberg, MD

Learning Objectives

Upon completion of this activity, participants will be able to:

• Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies
• Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms
• Diagnose challenging cases that do not readily conform to well-established entities
• Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy

Speakers

• Elizabeth A. Morgan, MD
• Valentina Nardi, MD
• Robert P. Hasserjian, MD
• Judith A. Ferry, MD
• Sam Sadigh, MD
• Abner Louissaint Jr., MD, PhD
• Scott B. Lovitch, MD, PhD
• Marian H. Harris, MD, PhD
• Aliyah R. Sohani, MD
• Yasodha Natkunam, MD, PhD
• Elizabeth Courville, MD
• Olga K. Weinberg, MD
• Olga Pozdnyakova, MD, PhD
• Sa A. Wang, MD
• Annette S. Kim, MD, PhD
• Scott J. Rodig, MD, PhD
• Kathleen H. Burns, MD, PhD
• Roberto Chiarle, MD
• Jacob R. Bledsoe, MD
• Gabriel K. Griffin, MD
• Mark D. Fleming, MD, DPhil
• Lawrence R. Zukerberg, MD

Target Audience

This course is designed for specialty physicians practicing in pathology who seek to strengthen their expertise in hematopathology diagnosis and ancillary testing strategies.

Why This Topic Matters

Current Concepts in Hematopathology 2022 ( VIDEOS) provides specialized educational content critical to advancing diagnostic proficiency within the field of hematopathology. Its focus on morphologic, immunophenotypic, cytogenetic, and molecular approaches equips professionals with current insights applicable to complex hematolymphoid disorders.

By aligning with the needs of pathology specialists, this program supports the ongoing development of competency in hematopathology, reflecting MedHub Central’s commitment to providing relevant, clinically focused education for improving professional practice.